Who is sponsoring NCT05993169?

NCT05993169 is sponsored by Jacob M. Elkins.

What drugs are being tested in NCT05993169?

Interventions in NCT05993169: Body Composition optimization visits.

What condition does NCT05993169 study?

NCT05993169 studies Obesity, Morbid.

Is NCT05993169 still recruiting?

NCT05993169 is currently terminated. Last updated 27 December 2023.

Last reviewed 2023-12-27 · How we verify

NCT05993169

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Body Composition Optimization Intervention RCT

Terminated NA Last updated 27 December 2023

What this trial tests

NA trial testing Body Composition optimization visits in Obesity, Morbid in 12 participants. Terminated before completion.

Timeline

15 September 2023

Primary endpoint
14 December 2023

14 December 2023

Quick facts

Lead sponsor	Jacob M. Elkins
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	12
Start date	15 September 2023
Primary completion	14 December 2023
Estimated completion	14 December 2023
Sites	1 location across United States

Drugs / interventions tested

Body Composition optimization visits

Conditions studied

Obesity, Morbid — all drugs for Obesity, Morbid →

Sponsor

Jacob M. Elkins

Who can join

Adults 18 to 99, any sex, with Obesity, Morbid. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to identify if the addition of structured nutrition/weight loss counseling to patients at the bariatric clinic can increase the conversion from bariatric clinic to surgical candidacy from (the current) 11% to a goal of 20% by way of tracking their BIA measurements.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Obesity, Morbid

Currently open trials in the same condition.

NCT07119437 — Low Impact Laparoscopy In Bariatric Surgery · NA · recruiting
NCT05927519 — Comparison of Airtraq in Class 2-3 Obese and Nonobese Men During Intubation: a Prospective Randomized Clinical Study · NA · recruiting
NCT06530212 — Sleeve Gastrectomy With Jejuno-ileal Bypass Versus Single Anastomosis Sleeve Jejunal Bypass · NA · recruiting
NCT06477120 — Time-restricted Eating Among Pregnant Females With Severe Obesity · NA · recruiting
NCT06119516 — Transpulmonary Pressure - Guided Mechanical Ventilation in Morbidly Obese ARDS Patients: a Feasibility Study. · NA · recruiting

Other Jacob M. Elkins trials

Trials by the same sponsor.

NCT06019832 — Analysis of Varus Collapse in Obese Patients With Stem and Non-Stem Tibial Components Following Primary Total Knee Arthr · NA · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05993169 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Jacob M. Elkins
Last refreshed: 27 December 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05993169.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing